Nutex Health Reports Preliminary Financial Results
Nutex Health Inc. (NASDAQ: NUTX), a physician-led integrated healthcare system, has released its preliminary financial results, revealing significant growth. The company operates an impressive network of 24 micro hospitals and outpatient departments, serving a diverse range of patients across various states.
Delay in Filing Financial Statements
Recently, Nutex Health announced a delay in filing its Form 10-Q ending June 30, 2025, due to non-cash accounting adjustments. These adjustments pertain to stock-based compensation obligations for several hospitals currently under construction. Despite this delay, the company reassures stakeholders that these adjustments will not impact revenue, gross profit, or liquidity.
Working with Auditors
The company is collaborating closely with its auditors to resolve the issues swiftly. Nutex Health aims to file the updated Form 10-Q within the SEC's five-day grace period, demonstrating its commitment to transparency and compliance.
Preliminary Financial Highlights
Nutex Health has shared select preliminary unaudited financial results for the second quarter of 2025, showcasing robust growth. The company recorded total revenue of $244 million for the quarter, marking a stunning increase of 220.7% compared to the same period in 2024. This growth is attributed to established hospitals, which saw a revenue increase of 203.2%.
Quarterly and Half-Year Performance
In addition, the gross profit for the quarter reached $124.9 million, representing 51.2% of total revenue, compared to just $22.6 million, or 29.7%, from the previous year. Patient visits in the Hospital Division also rose, reaching 45,573, which is an increase of 10.6% from last year. For the first half of 2025, total revenue was $455.8 million, a significant rise of 217.5%, and gross profit was $243.3 million.
Stock Repurchase Program Launch
Nutex Health's Board of Directors has authorized a share repurchase program of up to $25 million. This initiative aims to enhance shareholder value and combat dilution from future stock compensation obligations. The program will commence once the Form 10-Q is filed and strategies for repurchasing shares include open market transactions compliant with existing securities laws.
Consideration of Market Factors
The timing and quantity of shares repurchased will depend on various factors, including market conditions and the company’s financial health. Nutex Health retains the discretion to adjust or discontinue the repurchase program based on these influencing elements.
About Nutex Health Inc.
Founded in 2011 and headquartered in Houston, Texas, Nutex Health Inc. (NASDAQ: NUTX) is dedicated to revolutionizing healthcare management. The company operates two primary divisions: a Hospital Division and a Population Health Management Division. The Hospital Division is focused on developing innovative healthcare models, while the Population Health Management Division oversees provider networks and offers vital support services to affiliated hospitals and physician groups.
Frequently Asked Questions
What financial results did Nutex Health share?
Nutex Health reported a revenue of $244 million for Q2 2025, reflecting a growth rate of over 220% from the previous year.
Why is Nutex Health delaying its 10-Q filing?
The delay is due to non-cash accounting adjustments related to stock-based compensation for several hospitals currently under construction.
What is the company’s stock repurchase program?
The company has authorized a $25 million stock repurchase plan to enhance shareholder value and mitigate future dilution.
How many hospitals does Nutex Health operate?
Nutex Health operates 24 micro hospitals and outpatient departments across multiple states.
What does Nutex Health aim to achieve with the delays and financial strategies?
The company aims to maintain transparency while ensuring compliance and addressing financial health through strategic initiatives.
